Updates

July 30, 2020July 30, 2020
Collaboration Seeks to Reduce Prostate Cancer Disparities in African Americans

The Prostate Cancer Foundation (PCF) and Robert F. Smith, chairman and CEO of Vista Equity Partners are supporting research on a new non-invasive genetic ... Read more
July 28, 2020July 28, 2020
New Guidelines for Care of Advanced Prostate Cancer Released

The American Urological Association (AUA), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) have released new guidelines for the diagnosis ... Read more
July 23, 2020July 23, 2020
New Risk Calculator May Help Men With High PSA Decide on Having Prostate Biopsy

A new risk calculator may help men with high levels of prostate-specific antigen (PSA) — a marker of prostate cancer — to decide if ... Read more
July 21, 2020July 21, 2020
First AI-based Cancer Detection Application Slated for UK Rollout

Ibex Medical Analytics and LDPath have announced the rollout of the first clinical-grade artificial intelligence (AI) applications for pathology-based prostate cancer detection in the U.K. ... Read more
July 15, 2020July 15, 2020
Laser Focal Therapy Effective, Causes Few Side Effects, 10-Year Trial Data Shows

Image-guided laser focal therapy is as effective as radical prostate removal surgery at treating men with localized prostate cancer, without the added risks of ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

September 12, 2017September 12, 2017

Two High-Risk Prostate Cancer Treatments Have Similar Benefits, Add-On Study Finds

News

Two treatment approaches — Zytiga (abiraterone acetate) plus prednisolone (AAP) or Taxotere (docetaxel) — provided patients with high-risk prostate cancer similar benefits when added to standard hormone deprivation therapy, according to data recently presented at the European ... Read more

Collaboration Seeks to Reduce Prostate Cancer Disparities in African Americans

New Guidelines for Care of Advanced Prostate Cancer Released

New Risk Calculator May Help Men With High PSA Decide on Having Prostate Biopsy

First AI-based Cancer Detection Application Slated for UK Rollout

Laser Focal Therapy Effective, Causes Few Side Effects, 10-Year Trial Data Shows

University of Colorado Launches PreView Medical for PC Diagnosis, Treatment

Vaccine Shows Promise in Advanced Prostate Cancer, Proof-of-Concept Study Shows

FDA’s New ‘Project Patient Voice’ to Share Symptoms Data From Cancer Trials

Ipatasertib Combo Fares Well in Early Results of IPATential150 Phase 3 Study

Relugolix Granted FDA Priority Review as New Treatment Type

Recommendation Against PSA Routine Screening May Have Contributed to Higher Rates of Advanced PC

Subscribe to our mailing list

Veyonda Aids Radiation Therapy in Reaching Distant Lesions in Late-stage Cancer Trial

Cancer DNA Levels in Blood Can Predict Treatment Responses

Xtandi Plus ADT Bolsters Survival in High-risk Patients, Phase 3 Trial Finds

U.K. Study to Examine Genetic Screening for Large Prostate Cancer Population

NHS England Offers Xtandi, Zytiga to New PC Patients During COVID-19 Pandemic

ADT May Protect Prostate Cancer Patients from COVID-19, Study Suggests

Updated Guidelines Recommend Rubraca for Some Prostate Cancer Patients

Rubraca Receives Conditional FDA Approval for metastatic CRPC Patients with BRCA Mutations

FDA Approves Lynparza for mCRPC Patients with Mutations in DNA Repair Genes

Erleada Add-on Significantly Extends Survival in Non-metastatic CRPC, SPARTAN Analysis Shows

Yervoy Can Benefit Certain mCRPC Patients with Few Mutations in Tumors, Trial Finds

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

FDA Asked to Approve Relugolix to Treat Advanced Prostate Cancer

Cancer Vaccine Plus Opdivo Showing Promise in Advanced Prostate Cancer Trial

Gene Variant Seen to Promote Castration-resistant Disease in Whites

Winners Named for Prostate Cancer Foundation’s TRUE Love Awareness Contest

Guidelines for Radiation Therapy with COVID-19 Urge Less Treatment

Combining Two Biopsy Methods Improves PC Diagnosis, Study Shows

Urine Biomarkers Can Be Used to Develop Test for Prostate Cancer, Study Finds

Proscia and UCSF Partnering to Deliver AI Apps to Improve Cancer Diagnosis

Veru Advances Prostate Cancer Therapy VERU-111 to Phase 2 Portion of Trial

Adoptive Cell Therapy Can Slow Prostate Cancer Growth, Study in Mice Reports

Ciforadenant Has Promising Anti-tumor Activity in mCRPC, Early Data Show

Prolaris Test Predicts Which PC Patients Benefit from Combo Therapy, Study Finds

3 New miR Scientific Urine Tests Diagnose, Classify Prostate Cancer, Data Shows

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

Genetic Test Seen to Predict Patients Helped by ADT Use After Surgery

Statins, Metformin May Extend Survival in High-risk Prostate Cancer, Large Study Suggests

Decipher GRID ‘Signature’ Predicts Chemo Benefits in HSPC, Research Shows

High Vegetable Diet Does Not Halt Prostate Cancer, Study Finds

Pin It on Pinterest